Triad Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Triad Financial Advisors's LLY Position: Q3 2023 in Review
Triad Financial Advisors increased its Eli Lilly (LLY) stake by 6.5% in Q3 2023, buying an estimated $37.6K and bringing the position to 1,196 shares worth $642K. The position accounts for 0.23% of the portfolio, ranked #43.
Triad Financial Advisors first reported a position in LLY in Q4 2021 and has held it in 8 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- Triad Financial Advisors held 1,196 shares of Eli Lilly worth $642K as of Q3 2023.
- Triad Financial Advisors bought 73 Eli Lilly shares in Q3 2023, an estimated $37.6K.
- Eli Lilly made up 0.23% of Triad Financial Advisors's portfolio in Q3 2023, its #43 holding.
- Triad Financial Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 8 quarters since.
- 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on Triad Financial Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.